Fintel on MSN

B of A Securities Maintains CRISPR Therapeutics (CRSP) Buy Recommendation

Fintel reports that on October 17, 2025, B of A Securities maintained coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a ...
Medscape

Progress and Pressure: Taking Stock of the CRISPR Landscape

Despite setbacks and funding cuts — and a quieting of the hype blaring its arrival — multiple CRISPR-based trials are ...

CRISPR Therapeutics files for $600M stock offering

CRISPR Therapeutics (CRSP) has filed a prospectus supplement with the U.S. SEC to sell up to $600 million worth of its common ...
STAT

Baby KJ’s doctors will ask FDA this winter to OK a clinical trial of pioneering gene editing approach

Baby KJ's medical team intend to ask the FDA to start a clinical trial that would be open to patients with seven different ...
Securities.io

Next-Gen CRISPR Boosts Accuracy in Gene Therapy

Since 2019, MIT researchers have published a new concept called prime editing, which is more precise than regular CRISPR-Cas9 gene editing. As a result, it has fewer off-target effects and less chance ...
TipRanks on MSN

Crispr Therapeutics AG Files $600M Share Offering

Crispr Therapeutics AG ( ($CRSP) ) has issued an update. On October 15, 2025, CRISPR Therapeutics AG announced the filing of a prospectus ...
eLife

Explainable machine learning-assisted exploration of chromatin dynamics reveals chromosome-specific response to serum starvation

This interesting study adapts machine learning tools to analyze movements of a chromatin locus in living cells in response to serum starvation. The machine learning approach developed is useful, the ...